Ticker Attention Investors: Note: The depositories (CDSL/NSDL), in coordination with SEBI, have upgraded their investor mobile applications to provide a consolidated view of investors’ holdings in securities markets. CDSL: MyEasiApp | NSDL: Speede App Beware of fraudulent Calls, SMS, Emails, WhatsApp & Telegram messages assuring high returns and / or enticing you to invest money in the name of Aditya Birla Money by installing fake App from spurious links. You can download our Elevate App only from Google Play Store or Apple App Store or login to Elevate Web portal. Click Here to know more.

Aditya Birla Money Limited

Aditya Birla Money Limited

TTK Healthcare Ltd

Symbol : TTKHLTCARE | BSE Code : 507747 | Sector : DIVERSIFIED - MEDIUM / SMALL

907.50-8.85 (-0.97%)
01-Jul-2026 | 12:00
Loading

Market Cap (₹ Cr.)

1,282.33
Today’s High / Low
932.45
904.20
52 Week High / Low
1,398.90
735.00
907.50-3.55 (-0.39%)
01-Jul-2026 | 12:00
Loading

Market Cap (₹ Cr.)

1,282.33
Today’s High / Low
923.00
907.50
52 Week High / Low
1,402.00
737.00
907.50-8.85 (-0.97%)
01-Jul-2026 | 12:00

Turnover (₹ Cr.)

34,287,086,601.00
Today’s High / Low
58,390
57,859.80
907.50-8.85 (-0.97%)
01-Jul-2026 | 12:00

Turnover (₹ Cr.)

10,922,661.75
Today’s High / Low
1,360
1,315.00
OVERVIEW
  • Open
  • 920.30
  • Prev. Close
  • 916.35
  • High
  • 932.45
  • Low
  • 904.20
  • Market Cap (₹ Cr.)
  • 1,282.33
  • 52 Week High
  • 1,398.90
  • 52 Week Low
  • 735.00
  • Traded Volume (Lacs)
  • 1,862
  • Traded Value (Cr)
  • Dividend Yield
  • 1.10
  • Face Value
  • 10.00
  • EPS
  • 48.76
  • P/E
  • 18.68
  • Beta (1 year)
  • 1.02
OVERVIEW
  • Open
  • 920.00
  • Prev. Close
  • 911.05
  • High
  • 923.00
  • Low
  • 907.50
  • Market Cap (₹ Cr.)
  • 1,282.33
  • 52 Week High
  • 1,402.00
  • 52 Week Low
  • 737.00
  • Traded Volume (Lacs)
  • 21
  • Traded Value (Cr)
  • Dividend Yield
  • 1.10
  • Face Value
  • 10.00
  • EPS
  • 48.76
  • P/E
  • 18.68
  • Beta (1 year)
OVERVIEW
  • Open
  • 57,991.00
  • Prev. Close
  • 57,991.20
  • High
  • 58,390
  • Low
  • 57,859.80
  • Strike Price
  • 0.00
  • Open Interest(Nos.)
  • 2,210,370.00
  • OI Change %
  • 1.03
  • Volume(Lacs)
  • 1.03
  • Lot Size
  • 30.00
  • Average Price
  • 58,196.69
  • OI Difference
  • 22,590.00
  • Previous OI
  • 2,187,780.00
OVERVIEW
  • Open
  • 1,315.00
  • Prev. Close
  • 1,252.05
  • High
  • 1,360
  • Low
  • 1,315.00
  • Strike Price
  • 22,800.00
  • Open Interest(Nos.)
  • 15,795.00
  • OI Change %
  • 0.00
  • Volume(Lacs)
  • 0.00
  • Lot Size
  • 65.00
  • Average Price
  • 1,343.24
  • OI Difference
  • 0.00
  • Previous OI
  • 15,795.00
LAST 5 DAYS

1 YEAR RETURN - UNDERPERFORMED THE SENSEX BY 20.42%

  • 01/07/2026 BSE
    -3.55(-0.39)
    Close Price: ₹ 907.50
    Volume: 21.00

    01-Jul-2026
  • 01/07/2026 BSE
    -14.25(-1.54)
    Close Price: ₹ 911.05
    Volume: 31.00

    30-Jun-2026
  • 01/07/2026 BSE
    1.95(0.21)
    Close Price: ₹ 925.30
    Volume: 139.00

    29-Jun-2026
  • 01/07/2026 BSE
    4.35(0.47)
    Close Price: ₹ 923.35
    Volume: 135.00

    25-Jun-2026
  • 01/07/2026 BSE
    -2.75(-0.30)
    Close Price: ₹ 919.00
    Volume: 89.00

    24-Jun-2026

1 YEAR RETURN - UNDERPERFORMED THE SENSEX BY 20.42%

  • Stock Absolute
  • -1.16
  • -0.99
  • -28.95
  • -26.92
  • 34.45
  • Returns
  • 1W
  • 1M
  • 1Y
  • 3Y
  • 5Y
  • Sensex Absolute
  • 0.36
  • 2.98
  • -8.53
  • 18.17
  • 45.72
NEWS

TTK Healthcare schedules AGM

03-Jun-2026

No Data Available

TTK Healthcare announced that the 68th Annual General Meeting(AGM) of the company will be held on 24 July 2026.

03
Jun

TTK Healthcare schedules AGM



03
Jun

TTK Healthcare fixes record date for dividend



01
Jun

Board of TTK Healthcare recommends final dividend



FINANCIAL DATA

In Cr.

Mar 2026Mar 2025Mar 2024
SOURCES OF FUNDS :   
Share Capital 14.1314.1314.13
Reserves Total 1,100.721,050.92986.79
Equity Share Warrants0.000.000.00
Equity Application Money0.000.000.00
Read More
Mar 2026Mar 2025Mar 2024
INCOME :   
Sales Turnover 888.58825.87752.79
Excise Duty0.000.000.00
Net Sales888.58825.87752.79
Other Income 72.1585.1662.61
Read More
ParticularsMar 2026Dec 2025Sep 2025
Gross Sales 217.98209.30203.57
Excise Duty 000
Net Sales 217.98209.30203.57
Other Operating Income 000
Other Income  21.2717.4319.01
Read More
Category No. Of Shares Percentage (%)
Total Foreign 462271 3.27
Total Institutions 156500 1.11
Total Govt Holding 0 0.00
Total Non Promoter Corporate Holding 580969 4.11
Total Promoters 10535840 74.56
Total Public & others 2,394,753.00 16.95
Total 100.00 100.00
Read More
CORPORATE ACTIONS
Record Date Ex-Bonus Date Ratio
nodata
No Data Available!!!
Read More
Record Date Split Date Face Value Before Face Value After
nodata
No Data Available!!!
Read More
Read More
ANNOUNCEMENT DATE EX DIVIDEND DATE DIVIDEND (%) DIVIDEND TYPE
30-05-2026 17-07-2026 100 Final
23-05-2025 18-07-2025 100 Final
24-05-2024 16-07-2024 100 Final
23-05-2023 18-07-2023 100 Final
23-05-2022 26-07-2022 100 Final
PREMIUM (₹) RATIO RECORD DATE EX RIGHTS DATE
nodata
No Data Available!!!
Read More
Read More
FROM DATE EX TO DATE AGENDA
01-11-2026 NA Approved the reappointment of ...
24-07-2026 NA AGM 24/07/2026. Outcome of ...
18-07-2026 24-07-2026 The Register of Members and th...
17-07-2026 NA Rs.10.0000 per share(100%)Fina...
17-07-2026 NA 100% Final Dividend
COMPANY INFO

TTK Healthcare Limited, a TTK Group Company was incorporated in May 1958 as Orient Pharma and later renamed as TTK Pharma in Nov '81. The Company is the owner of famous Woodwards Gripewater brand. The Company operate into five main Strategic Business Units namely, Pharmaceuticals, Consumer Products, Medical Devices, Foods and Protective Devices divisions. It is engaged into Animal Welfare Products, Consumer Products, Medical Devices, Protective Devices and Foods Businesses.

In 1992, the company came out with a rights issue at a premium of Rs 35 aggregating Rs 5.81 cr to finance long-term working capital needs, normal capital expenditure, and product promotion.

Products of TTK Healthcare include cardiac care systems, blood management systems, renal care systems, hospital accessories, antibiotics, Woodwards gripe water, animal medicines, etc.

It also has a consumer products and food division manufacturing kiwi shoe polishes, snacks, etc. The company has collaborations with a number of foreign corporations such as London International, Kali-Chemi, Germany; Hatu-ICO, Spain; Nicholas Kiwi, US, etc. The products of the company are exported to the UK, Egypt, the US, Germany, Singapore, Malaysia, Carribean countries, etc.

The Pallavaram plant of the company has been accredited with the ISO 14002 certification by the Bureau of Indian Standards. Also, one of the group companies, TT Maps and Publications was merged with TTK Pharma in 1993.

The company faced some rough weather in Jul.'95 when the MRTPC ordered an inquiry against it for allegedly directing its whole-salers to keep a minimum stock of the company's products and defining their area of operations. During 1996-97, the company has tied up with M/s Mentholatum India Pvt Ltd.

During the year 1999-2000, as a part of the restructuring programme, the paper divison of the company has been disposed off and the merger of TTK Biomed has been approved by the Hon'ble High Court Of Madras with retrospective e

Read More
Get Free Demat Account
Captcha Image